Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-665
Closed -$207K 69
2025
Q1
$207K Sell
665
-440
-40% -$130K 0.18% 91
2024
Q4
$288K Sell
1,105
-25
-2% -$7.42K 0.23% 76
2024
Q3
$364K Buy
1,130
+2
+0.2% +$654 0.27% 61
2024
Q2
$352K Buy
1,128
+81
+8% +$23.8K 0.28% 59
2024
Q1
$298K Buy
1,047
+11
+1% +$3.22K 0.26% 60
2023
Q4
$298K Sell
1,036
-5
-0.5% -$1.36K 0.27% 54
2023
Q3
$280K Hold
1,041
0.28% 53
2023
Q2
$231K Sell
1,041
-7
-0.7% -$1.62K 0.25% 64
2023
Q1
$253K Hold
1,048
0.3% 61
2022
Q4
$275K Hold
1,048
0.3% 62
2022
Q3
$236K Hold
1,048
0.24% 70
2022
Q2
$255K Sell
1,048
-75
-7% -$18.4K 0.23% 78
2022
Q1
$272K Hold
1,123
0.2% 96
2021
Q4
$253K Sell
1,123
-219
-16% -$46.2K 0.18% 109
2021
Q3
$285K Sell
1,342
-50
-4% -$11.5K 0.23% 92
2021
Q2
$339K Sell
1,392
-230
-14% -$56.6K 0.27% 76
2021
Q1
$404K Hold
1,622
0.46% 65
2020
Q4
$373K Buy
1,622
+10
+0.6% +$2.31K 0.43% 59
2020
Q3
$410K Hold
1,612
0.51% 52
2020
Q2
$384K Sell
1,612
-145
-8% -$33.1K 0.48% 54
2020
Q1
$356K Sell
1,757
-100
-5% -$21.8K 0.44% 47
2019
Q4
$448K Buy
+1,857
New +$409K 0.48% 44

Other funds holding AMGN

Indie Asset Partners's AMGN Position: Q2 2025 in Review

Indie Asset Partners sold out of Amgen (AMGN) in Q2 2025, closing a stake of 665 shares — an estimated $207K sold.

Indie Asset Partners first reported a position in AMGN in Q4 2019 and held it in 22 quarters. The position peaked at $448K in Q4 2019. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Indie Asset Partners reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Indie Asset Partners sold 665 Amgen shares in Q2 2025, an estimated $207K.
  • Indie Asset Partners first reported a position in Amgen in Q4 2019 and held it in 22 quarters.
  • Indie Asset Partners's Amgen position peaked at $448K in Q4 2019.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Indie Asset Partners's 13F filing for Q2 2025, filed 12 Aug 2025.